Abstract: The invention is directed to a mediated metal-sulfur flow battery. This battery format that is readily scalable to grid-scale levels at low cost, while maintaining battery safety by physically separating the anode and cathode. As an example, the marriage of a redox-targeting scheme to an engineered Li solid electrolyte interphase (SEI) enables a scalable, high efficiency, membrane-less Li—S redox flow battery. Redox mediators can be sued to kick-start the initial reduction of solid S into soluble polysulfides on the cathode side and final reduction of polysulfides into solid Li2S, precluding the need for conductive carbons. On the anode side, a LiI and LiNO3 pretreatment and additive strategy encourages a stable SEI and lessens capacity fade, avoiding the need for ion-selective separators.

Abstract: Provided herein are compounds of Formula (I) and pharmaceutically acceptable salts or tautomers thereof which may inhibit adenylate-forming enzymes. Also provided are pharmaceutical compositions, kits, uses, and methods involving the inventive compounds for the treatment and/or prevention of an infectious disease (e.g., bacterial infection (e.g., tuberculosis, methicillin-resistant Staphylococcus aureus)).

Abstract: The present invention relates to GLP-1 and/or glucagon receptor agonists (for example, oxyntomodulin peptide analogs), pharmaceutically acceptable salts thereof, formulations comprising the same, and uses thereof for treating diabetes and/or obesity or associated diseases or disorders.

Abstract: A method may be directed towards promoting one or more socially beneficial objectives. The social objective may be, in one embodiment, safe management of trash in a location in one or more developing countries. The method may include providing a mobile game to a player. The game may educate the players of the game with regard to the objectives. The method may include providing a plurality of challenges to the player. The challenges may be related to one or more local initiatives. The challenges may include queries related to at least one of the local initiatives. In some embodiments, the local initiative includes refuse disposal. The method may include making donations to an organization based on actions or outcomes in the game. The organization may use the donations to further the local initiative.

Abstract: A lighting control system is disclosed. The lighting control system is electrically coupled to a load circuit for controlling indoor and/or outdoor lighting. The lighting control system includes a control module with a night light for providing low-level night light illumination and one or more sensors for operatively controlling the indoor and/or outdoor lighting and the night light in response to measured light levels and/or detected motion. The system is preferably configured to provide low-level night light from the night light when measured light levels and detected motion are below threshold values and to automatically turn on the indoor and/or outdoor lighting and simultaneously turn off the night light when measured light levels and detected motion are above the threshold values.

Abstract: Waterborne compositions comprising an aqueous dispersion comprising a latex are disclosed. Disclosed are latexes that are the reaction product of reactants that include a ureido-functional ethylenically unsaturated compound, an ethylenically unsaturated silicone, and another ethylenically unsaturated compound. Use of such composition to treat porous substrate is also disclosed.

Abstract: The present invention relates to otoscopes and more specifically to musical or sound emitting otoscopes that may serve to calm pediatric patient or patients with emotional or developmental disabilities. The musical otoscope incorporates a head capable of receiving a speculum, a speaker mounted within the head and a sound reproduction apparatus for driving the speaker. The head of the otoscope may include a housing having a front side, a rear side and an interior space, the rear side having a magnifying lens, the front side receives a base of the and a speaker mounted within the housing, where the speaker is linked to a sound reproduction apparatus for driving the speaker is presented. The sound reproduction device may be an MP3 player or any other device that includes a power source, a micro controller/processor, a digital signal processor and a digital to analog converter. The use of a sound emitting otoscope has been found to ease patient diagnosis and care.

Abstract: A lighting control system is disclosed. The lighting control system is electrically coupled to a load circuit for controlling indoor and/or outdoor lighting. The lighting control system includes a control module with a night light for providing low-level night light illumination and one or more sensors for operatively controlling the indoor and/or outdoor lighting and the night light in response to measured light levels and/or detected motion.

Abstract: A lighting control system is disclosed. The lighting control system is electrically coupled to a load circuit for controlling indoor and/or outdoor lighting. The lighting control system includes a control module with a night light for providing low-level night light illumination and one or more sensors for operatively controlling the indoor and/or outdoor lighting and the night light in response to measured light levels and/or detected motion. The system is preferably configured to provide low-level night light from the night light when measured light levels and detected motion are below threshold values and to automatically turn on the indoor and/or outdoor lighting and simultaneously turn off the night light when measured light levels and detected motion are above the threshold values.

Abstract: A lighting control system is disclosed. The lighting control system is electrically coupled to a load circuit for controlling indoor and/or outdoor lighting. The lighting control system includes a control module with a night light for providing low-level night light illumination and one or more sensors for operatively controlling the indoor and/or outdoor lighting and the night light in response to measured light levels and/or detected motion. The system is preferably configured to provide low-level night light from the night light when measured light levels and detected motion are below threshold values and to automatically turn on the indoor and/or outdoor lighting and simultaneously turn off the night light when measured light levels and detected motion are above the threshold values.

Abstract: A light management system for controlling a load circuit is disclosed. The system preferably comprises a switch unit with a momentary switch for manually controlling the load circuit, a night light to provide low-level or reduced room lighting from the switch unit and a motion sensor for sensing motion from the switch unit. The motion sensor is configured to automatically control the load circuit and/or the night light based on detected motion. In a preferred embodiment of the invention, the load circuit operates a room lighting system, the light unit comprises light emitting diodes to provide the low-level light. The switch unit is preferably programmable to customized modes of operation to suit a wide range of applications. In yet further embodiments of the invention, the system comprises a light sensor for controlling the load circuit or the night light in response to a level of detected room lighting.

Abstract: The present invention relates to a method of treatment of a condition or disease selected from the group consisting of hypertension, left ventricular dysfunction and hypertrophic cardiomyopathy, diabetic cardiac myopathy, supraventricular and ventricular arrhythmias, atrial fibrillation, atrial flutter, detrimental vascular remodeling, myocardial infarction and its sequelae, atherosclerosis, angina (whether unstable or stable), renal insufficiency (diabetic and non-diabetic), heart failure, angina pectoris, diabetes, secondary aldosteronism, primary and secondary pulmonary hypertension, renal failure conditions, such as diabetic nephropathy, glomerulonephritis, scleroderma, glomerular sclerosis, proteinuria of primary renal disease, and also renal vascular hypertension, diabetic retinopathy, the management of other vascular disorders, such as migraine, peripheral vascular disease, Raynaud's disease, luminal hyperplasia, endothelial dysfunction, cognitive dysfunction (such as Alzheimer's), glaucoma and stroke,